Literature DB >> 12775741

Patient preference for radiotherapy fractionation schedule in the palliation of painful bone metastases.

Thomas P Shakespeare1, Jiade J Lu, Michael F Back, Shen Liang, Rahul K Mukherjee, Christopher J Wynne.   

Abstract

PURPOSE: The radiotherapeutic management of painful bone metastases is controversial, with several institutional and national guidelines advocating use of single-fraction radiotherapy. We aimed to determine patient choice of fractionation schedule after involvement in the decision-making process by use of a decision board. PATIENTS AND METHODS: Advantages and disadvantages of two fractionation schedules (24 Gy in six fractions v 8 Gy in one fraction) used in the randomized Dutch Bone Metastasis Study were discussed with patients using a decision board. Patients were asked to choose a fractionation schedule, to give reasons for their choice, and to indicate level of satisfaction with being involved in decision making.
RESULTS: Sixty-two patients were entered. Eighty-five percent (95% confidence interval, 74% to 93%) chose 24 Gy in six fractions over 8 Gy in one fraction (P <.0005). Variables including age, sex, performance status, tumor type, pain score, and paying class were not significantly related to patient choice. Multiple fractionation was chosen for lower re-treatment rates (92%) and fewer fractures (32%). Single-fraction treatment was chosen for cost (11%) and convenience (89%). Eighty-four percent of patients expressed positive opinions about being involved in the decision-making process.
CONCLUSION: Decision board instruments are feasible and acceptable in an Asian population. The vast majority of patients preferred 24 Gy fractionated radiotherapy compared with a single fraction of 8 Gy. These results indicate the need for further research in this important area and serve to remind both clinicians and national or institutional policy makers of the importance of individual patient preference in treatment decision making.

Entities:  

Mesh:

Year:  2003        PMID: 12775741     DOI: 10.1200/JCO.2003.10.112

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  14 in total

1.  Relationship between morphine and radiotherapy for management of symptomatic bone metastases from lung cancer.

Authors:  Hiromichi Ishiyama; Akiko Shibata; Keiji Niino; Takaaki Hosoya
Journal:  Support Care Cancer       Date:  2004-10       Impact factor: 3.603

2.  Hypofractionated radiotherapy in the real-world setting: An international ESTRO-GIRO survey.

Authors:  Danielle Rodin; Bouchra Tawk; Osama Mohamad; Surbhi Grover; Fabio Y Moraes; Mei Ling Yap; Eduardo Zubizarreta; Yolande Lievens
Journal:  Radiother Oncol       Date:  2021-01-14       Impact factor: 6.280

3.  A Video Decision Aid Improves Informed Decision Making in Patients With Advanced Cancer Considering Palliative Radiation Therapy.

Authors:  Kavita V Dharmarajan; Chasity B Walters; Tomer T Levin; Carol Ann Milazzo; Christopher Monether; Robin Rawlins-Duell; Roma Tickoo; Daniel E Spratt; Shona Lovie; Gina Giannantoni-Ibelli; Beryl McCormick
Journal:  J Pain Symptom Manage       Date:  2019-08-28       Impact factor: 3.612

4.  Palliative radiation therapy practice in patients with metastatic non-small-cell lung cancer: a Cancer Care Outcomes Research and Surveillance Consortium (CanCORS) Study.

Authors:  Aileen B Chen; Angel Cronin; Jane C Weeks; Elizabeth A Chrischilles; Jennifer Malin; James A Hayman; Deborah Schrag
Journal:  J Clin Oncol       Date:  2013-01-07       Impact factor: 44.544

5.  European French-speaking study from the GEMO group on bone metastases management: a special focus on external beam radiotherapy practice survey.

Authors:  Nicolas Magné; Cyrus Chargari; René Olivier Mirimanoff; Pierre Olivier; Jean Philippe Vuillez; Michèle Tubiana-Hulin; Jean Jacques Body; Jean Léon Lagrange
Journal:  Support Care Cancer       Date:  2010-08-31       Impact factor: 3.603

6.  Knowledge and utilization of palliative radiotherapy by pediatric oncologists.

Authors:  T L Tucker; R S Samant; E J Fitzgibbon
Journal:  Curr Oncol       Date:  2010-02       Impact factor: 3.677

7.  Estimating Costs of Care Attributable to Cancer: Does the Choice of Comparison Group Matter?

Authors:  Aileen B Chen; Ling Li; Angel M Cronin; Gabriel A Brooks; Brian D Kavanagh; Deborah Schrag
Journal:  Health Serv Res       Date:  2017-08-31       Impact factor: 3.402

8.  Radiotherapy of Bone Metastasis in Breast Cancer Patients - Current Approaches.

Authors:  Petra C Feyer; Maria Steingraeber
Journal:  Breast Care (Basel)       Date:  2012-04-25       Impact factor: 2.860

9.  Choosing between conventional and hypofractionated prostate cancer radiation therapy: Results from a study of shared decision-making.

Authors:  Thomas P Shakespeare; Justin Westhuyzen; Tracy Lim Yew Fai; Noel J Aherne
Journal:  Rep Pract Oncol Radiother       Date:  2020-01-09

10.  Combine or separate future pain? The impact of current pain on decisions about future dental treatments.

Authors:  Eduardo B Andrade; Marco Aurélio Bianchini; Newton Lucchiari
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.